- Tel:
- Work +41 43 222 10 00
- Fax:
- Fax +41 43 222 15 00
- Web:
- www.homburger.ch
- Email:
STADA acquires generics business of Spirig
On January 31, 2012, STADA Arzneimittel AG, a German pharmaceutical company listed on the Frankfurt stock exchange, with headquarters in Bad Vilbel, successfully closed the acquisition of the generics business that has previously been spun off of the Swiss based Spirig Pharma AG. The purchase price amounts to approximately CHF 97 million.
Homburger acted as Swiss counsel to STADA with respect to the acquisition. The Homburger team was led by partner Daniel Daeniker (Corporate | M&A and Financial Services) and included partners Georg Rauber (IP | IT) and Reto Heuberger (Tax) as well as associates Daniel Hasler (Corporate | M&A), Andrea Rüttimann (Corporate | M&A), Emanuel Dettwiler (Corporate | M&A), Christof Burri (IP | IT), Richard Stäuber (IP | IT), Sergio Bortolani (IP | IT) and Beat Baumgartner (Tax).
For more information please visit www.homburger.ch
